New Zealand shares rose as Tower extended its gains from a 16-year-low and Orion Health Group climbed, with global equity markets gaining ahead of an announcement from the European Central Bank overnight that may include an extension to its quantitative easing.
The S&P/NZX50 Index gained 26.24 points, or 0.4 percent, to 6,916.01. Within the index, 30 stocks rose, 14 fell and seven were unchanged. Turnover was $138 million.
Tower led the index, up 5.2 percent to 81 cents. The stock has risen 13 percent since Nov. 29, when the insurer said it will separate its liabilities and receivables from the Canterbury earthquakes into a separate 'bad bank' structure and "aggressively pursue" recoveries from the EQC and reinsurer Peak Re that amount to about $101 million. It's down about 60 percent this year, dragged lower by investor concerns over the long tail of earthquake costs.
"It's taken a fairly severe beating of late, the jury's really out in terms of what they can actually do in forming new-co, old-co, how that would actually work if they can get it to work," said David Price, a broker at Forsyth Barr. 'It's coming off a relatively low base and turnover's pretty light. The work-through is going to take quite some time."
The local bourse has gained along with global indices ahead of the final announcement from the ECB's president Mario Draghi, where he is anticipated to announce an extension of asset purchases by the central bank beyond March 2017.